Extended Data Fig. 3: Gating strategy used to measure Omicron B.1.1.529.
From: An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
(A) Spike-specific effector T-cell responses and (B) B-cell population.
